Amgen Inc (AMGN)

Financial leverage ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total assets US$ in thousands 91,839,000 90,883,000 90,907,000 92,980,000 97,154,000 90,534,000 90,269,000 88,720,000 65,121,000 63,700,000 59,294,000 59,196,000 61,165,000 64,993,000 59,773,000 62,539,000 62,948,000 64,637,000 65,011,000 61,669,000
Total stockholders’ equity US$ in thousands 5,877,000 7,527,000 5,925,000 5,022,000 6,232,000 7,656,000 6,781,000 5,348,000 3,661,000 3,653,000 2,419,000 916,000 6,700,000 8,217,000 8,247,000 9,334,000 9,409,000 10,959,000 10,659,000 9,485,000
Financial leverage ratio 15.63 12.07 15.34 18.51 15.59 11.83 13.31 16.59 17.79 17.44 24.51 64.62 9.13 7.91 7.25 6.70 6.69 5.90 6.10 6.50

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $91,839,000K ÷ $5,877,000K
= 15.63

The financial leverage ratio of Amgen Inc has shown fluctuations over the past few years, indicating changes in the company's level of debt relative to its equity. From March 31, 2020, to December 31, 2021, the ratio increased steadily from 6.50 to 9.13, suggesting a higher reliance on debt to finance its operations during this period.

However, from March 31, 2022, to December 31, 2024, there were significant spikes and declines in the ratio, reaching a peak of 64.62 in March 31, 2022, and dropping to 12.07 in September 30, 2024. Such extreme fluctuations could indicate irregularities in the capital structure or debt management strategies of the company during this period.

It is essential for investors and stakeholders to closely monitor Amgen Inc's financial leverage ratio trends to assess the company's risk profile, financial stability, and ability to meet its debt obligations.


See also:

Amgen Inc Financial Leverage (Quarterly Data)